• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy!NRG/RTOG 9413的长期结果：一项关键研究，但也是前列腺癌放射治疗中最令人困惑的研究之一！
Transl Androl Urol. 2019 Jul;8(Suppl 3):S257-S260. doi: 10.21037/tau.2019.04.01.
2
Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202.长期激素治疗（与短期激素治疗相比）的效果：对接受NRG肿瘤学RTOG 9202治疗的中危前列腺癌患者的二次分析
Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):511-515. doi: 10.1016/j.ijrobp.2016.11.002. Epub 2016 Nov 8.
3
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.NRG 肿瘤学/RTOG0415 试验中前列腺癌分割放疗后晚期不良事件的耐受剂量。
Radiother Oncol. 2019 Jun;135:19-24. doi: 10.1016/j.radonc.2019.02.014. Epub 2019 Mar 5.
4
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.标准剂量与剂量递增放疗治疗中危前列腺癌患者的效果：NRG 肿瘤学 RTOG 0126 随机临床试验。
JAMA Oncol. 2018 Jun 14;4(6):e180039. doi: 10.1001/jamaoncol.2018.0039.
5
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.局部晚期前列腺癌中生化失败时间间隔作为替代终点：NRG/RTOG 9202 随机试验分析。
J Clin Oncol. 2019 Jan 20;37(3):213-221. doi: 10.1200/JCO.18.00154. Epub 2018 Dec 7.
6
Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer.回复：NRG肿瘤学RTOG 0415的长期分析：一项比较低风险前列腺癌患者两种分割方案的随机III期非劣效性研究。
Eur Urol. 2025 Mar;87(3):372-373. doi: 10.1016/j.eururo.2024.09.015. Epub 2024 Sep 26.
7
Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis.前列腺癌患者生化复发低、中、高风险患者的放疗联合激素治疗（RT-HT）：前景与治疗获益分析
Neoplasma. 2007;54(1):7-15.
8
[Radiotherapy combined with hormonal therapy as treatment method in patients with prostate cancer: still more questions than answers].[放射治疗联合激素治疗作为前列腺癌患者的治疗方法：问题仍多于答案]
Przegl Lek. 2005;62(12):1455-9.
9
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.局部晚期前列腺癌雄激素剥夺治疗的持续时间：NRG肿瘤学RTOG 9202的长期更新
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):296-303. doi: 10.1016/j.ijrobp.2017.02.004. Epub 2017 Feb 12.
10
Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.NRG肿瘤学组织的华盛顿大学生活质量问卷-RTOG修订版的探索性因素分析
J Pain Symptom Manage. 2017 Jan;53(1):139-145.e2. doi: 10.1016/j.jpainsymman.2016.11.002. Epub 2016 Nov 27.

本文引用的文献

1
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.激素治疗与放疗靶区大小在局部进展性前列腺癌中的研究（NRG/RTOG9413）：一项随机、3 期临床试验的长期结果。
Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10.
2
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial.根据个体放射敏感性评估辅助激素疗法对放射性乳腺纤维化的影响：一项法国多中心前瞻性试验的结果
Oncotarget. 2018 Mar 2;9(21):15757-15765. doi: 10.18632/oncotarget.24606. eCollection 2018 Mar 20.
3
Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials.常规放疗与前列腺癌局部放射治疗：随机非劣效性试验的荟萃分析。
Eur Urol Focus. 2019 Jul;5(4):577-584. doi: 10.1016/j.euf.2017.10.011. Epub 2017 Dec 5.
4
The Impact of Ga-PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study.镓-PSMA PET/CT 对前列腺癌管理意向的影响：一项澳大利亚前瞻性多中心研究的结果。
J Nucl Med. 2018 Jan;59(1):82-88. doi: 10.2967/jnumed.117.197160. Epub 2017 Jun 23.
5
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.随机分组试验：一种低分割辐射方案治疗局限性前列腺癌。
J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15.
6
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.雄激素抑制联合选择性淋巴结及剂量递增放射治疗（ASCENDE-RT试验）：一项针对高风险和中风险前列腺癌的随机试验的生存终点分析，该试验比较了低剂量率近距离放疗增敏与剂量递增外照射增敏。
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285. doi: 10.1016/j.ijrobp.2016.11.026. Epub 2016 Nov 24.
7
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.盆腔放疗在局限性前列腺腺癌中是否有作用？GETUG-01随机研究长期生存结果的更新
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455.
8
Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.来曲唑与辅助性乳腺癌放疗同时或序贯使用：CO-HO-RT II期随机试验的最终结果
Ann Oncol. 2016 Mar;27(3):474-80. doi: 10.1093/annonc/mdv602. Epub 2015 Dec 17.
9
Concurrent or Sequential Hormonal and Radiation Therapy in Breast Cancer: A Literature Review.乳腺癌的同步或序贯激素与放射治疗：文献综述
Cureus. 2015 Oct 25;7(10):e364. doi: 10.7759/cureus.364.
10
Adjuvant versus neoadjuvant androgen deprivation with radiotherapy for prostate cancer: does sequencing matter?辅助性雄激素剥夺与新辅助性雄激素剥夺联合放疗治疗前列腺癌：顺序重要吗？
Clin Genitourin Cancer. 2015 Jun;13(3):e183-9. doi: 10.1016/j.clgc.2014.12.009. Epub 2014 Dec 31.

Long term results of the NRG/RTOG 9413: a key study but one of the most confusing study in prostate cancer radiotherapy!

作者信息

Pommier Pascal

机构信息

Radiotherapy Department, Centre Leon Berard, Lyon Cedex 08, France.

出版信息

Transl Androl Urol. 2019 Jul;8(Suppl 3):S257-S260. doi: 10.21037/tau.2019.04.01.

DOI:10.21037/tau.2019.04.01
PMID:31392138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6642955/
Abstract
摘要